Gene · 2180
Papers2,026
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,026
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Progress in Early Diagnosis of Atherosclerosis. | Int J Mol Sci | 2022 | 36012202 | PubTator, text mining | PubMed |
| Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology. | Cells | 2022 | 36010595 | PubTator, text mining | PubMed |
| Does Childhood Obesity Trigger Neuroinflammation? | Biomedicines | 2022 | 36009499 | PubTator, text mining | PubMed |
| Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach. | Antioxidants (Basel) | 2022 | 36009223 | PubTator, text mining | PubMed |
| Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis. | Curr Issues Mol Biol | 2022 | 36005135 | PubTator, text mining | PubMed |
| Supporting Student Learning Needs in Tertiary Education: Institutional Support Structures Based on the Institutional Support Questionnaire. | Behav Sci (Basel) | 2022 | 36004848 | PubTator, text mining | PubMed |
| Single-cell transcriptomics uncover the key ferroptosis regulators contribute to cancer progression in head and neck squamous cell carcinoma. | Front Mol Biosci | 2022 | 36003082 | PubTator, text mining | PubMed |
| Altered expression of ACOX2 in non-small cell lung cancer. | BMC Pulm Med | 2022 | 35999530 | PubTator, text mining | PubMed |
| Phenotypic Plasticity - Alternate Transcriptional Programs Driving Treatment Resistant Prostate Cancer. | Crit Rev Oncog | 2022 | 35993978 | PubTator, text mining | PubMed |
| The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus. | PLoS One | 2022 | 35972968 | PubTator, text mining | PubMed |
| Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP). | J Cachexia Sarcopenia Muscle | 2022 | 35969116 | PubTator, text mining | PubMed |
| COVID-19 metabolism: Mechanisms and therapeutic targets. | MedComm (2020) | 2022 | 35958432 | PubTator, text mining | PubMed |
| Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer. | Cancers (Basel) | 2022 | 35954376 | PubTator, text mining | PubMed |
| Identification of Genes Predicting Poor Response of Trastuzumab in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer. | J Immunol Res | 2022 | 35935587 | PubTator, text mining | PubMed |
| A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes. | J Immunol Res | 2022 | 35935579 | PubTator, text mining | PubMed |
| Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. | Cell Stem Cell | 2022 | 35931030 | PubTator, text mining | PubMed |
| Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth. | Commun Biol | 2022 | 35918402 | PubTator, text mining | PubMed |
| ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics. | Front Pharmacol | 2022 | 35910359 | PubTator, text mining | PubMed |
| Bempedoic Acid: for Whom and When. | Curr Atheroscler Rep | 2022 | 35900636 | PubTator, text mining | PubMed |
| Postbiotic Gamma-Aminobutyric Acid and Camel Milk Intervention as Innovative Trends Against Hyperglycemia and Hyperlipidemia in Streptozotocin-Induced C57BL/6J Diabetic Mice. | Front Microbiol | 2022 | 35898909 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2180/papers?page=31